Items in cart [0] Questions? Call 888-624-8373

PAPERBACK + PDF your price: $46.00 add to cart PAPERBACK list:$39.00 Web:$35.10 add to cart PDF BOOK your price: $30.00 add to cart PDF CHAPTERS your price: $4.10 select Rights & Permissions Free Resources Display this book on your site! Related Titles Contraceptive Research and Development: Looking to the Future Growing Up Global: The Changing Transitions to Adulthood in Developing Countries Other Related Titles New Frontiers in Contraceptive Research: A Blueprint for Action (2004) Board on Health Sciences Policy (HSP) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 231   E-mail  Facebook  Digg  Stumble  Twitter More Page 231 Front Matter (R1-R16) Executive Summary (1-16) 1 Introduction (17-26) 2 Target Discovery and Validation (27-77) 3 Product Identification and Development (78-107) 4 Improving Contraceptive Use and Acceptability (108-133) 5 Capitalizing on Recent Scientific Advances (134-162) Appendix A: Examples of Progress and Impediments in Contraceptive Research and Development (163-201) Appendix B: Agendas and Participants in Committee Workshops (202-211) Appendix C: Committee Biographies (212-218) Glossary (219-230) Acronyms (231-232)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 231
Acronyms AIDS Acquired Immune Deficiency Syndrome AMPPA Application of Molecular Pharmacology for Post-Testicular Activity BLA Biologics License Application CDC Center for Disease Control and Prevention cDNA complementary DNA CICCR—Consortium for Industrial Collaboration in Contraceptive Research CIR-LRP Contraception and Infertility Loan Repayment Program EM Electron Microscopy EST Expressed Sequence Tag FDA Food and Drug Administration PHI Family Health International FIC/NIEHS Fogerty International Center/ National Institute of Environment Health Services FSH follicle stimulating hormone GATB Global Alliance for TB Drug Development GLP Good Laboratory Practice GMP Global Microbicide Project GMP Good Manufacturing Practice GnRH gonadotropin releasing hormone 231

OCR for page 232
232 GPI Glycosyl Phosphatidylinositol hCG human chorionic gonadotropin HIV Human Immuno-deficiency Virus HPTN HIV Prevention Trials Network HTS High Throughput Screening NEW FRONTIERS IN CONTRACEPTIVE RESEARCH ICCR International Committee for Contraception Research IND Investigational New Drug IOM Institute of Medicine IUD Intrauterine Device LCST Lower Critical Solution Temperature LNG-IUS Levonorgestrel-releasing intra-uterine system LH luteinizing hormone NCI National Cancer Institute NDA New Drug Application NICHD National Institute of Child Health and Human Development NIH National Institutes of Health NMR Nuclear Magnetic Resonance OR Olfactory Receptor ORE Open Reading Frame PQS Protein Quaternary Structure RAID Rapid acess to intervention development R.A.N.D rapid access to NCI discovery resources RNAi RNA interference SST Signal Sequence Trap STI Sexually Transmitted Infection UNFPA United Nations Population Fund USAID United States Agency for International Development USDA United States Department of Agriculture WHO World Health Organization

Representative terms from entire chapter:

pqs protein